Yunovia

Yunovia develops platform‑based therapeutics to prolong healthy lifespan and treat age‑related diseases.

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Yunovia develops platform‑based therapeutics to prolong healthy lifespan and treat age‑related diseases.

Proprietary biology and drug‑discovery platform targeting pathways that regulate cellular aging and health‑span.

Rising demand for longevity therapeutics and potential partnerships with pharma seeking anti‑aging pipelines.

Limited public data, early‑stage development, and intense competition from better‑funded longevity biotech firms.

Competes with established geroscience companies; differentiation will depend on unique targets and early efficacy data.